Icares Medicus Inc - Asset Resilience Ratio
Icares Medicus Inc (6612) has an Asset Resilience Ratio of 9.93% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Icares Medicus Inc (6612) total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2024)
This chart shows how Icares Medicus Inc's Asset Resilience Ratio has changed over time. See 6612 net asset value for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Icares Medicus Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Icares Medicus Inc.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$311.99 Million | 9.93% |
| Total Liquid Assets | NT$311.99 Million | 9.93% |
Asset Resilience Insights
- Limited Liquidity: Icares Medicus Inc maintains only 9.93% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Icares Medicus Inc Industry Peers by Asset Resilience Ratio
Compare Icares Medicus Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087 |
Medical Instruments & Supplies | 9.08% |
|
Vizionfocus Inc.
TW:4771 |
Medical Instruments & Supplies | 5.07% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 4.42% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 51.82% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 6.36% |
|
Austco Healthcare Ltd
AU:AHC |
Medical Instruments & Supplies | 15.90% |
|
Trajan Group Holdings Ltd
AU:TRJ |
Medical Instruments & Supplies | 0.23% |
|
Osteopore Ltd
AU:OSX |
Medical Instruments & Supplies | 43.09% |
Annual Asset Resilience Ratio for Icares Medicus Inc (2021–2024)
The table below shows the annual Asset Resilience Ratio data for Icares Medicus Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 10.32% | NT$310.36 Million ≈ $9.78 Million |
NT$3.01 Billion ≈ $94.77 Million |
-20.45pp |
| 2023-12-31 | 30.76% | NT$587.17 Million ≈ $18.50 Million |
NT$1.91 Billion ≈ $60.13 Million |
+17.13pp |
| 2022-12-31 | 13.64% | NT$142.29 Million ≈ $4.48 Million |
NT$1.04 Billion ≈ $32.87 Million |
+11.84pp |
| 2021-12-31 | 1.80% | NT$17.38 Million ≈ $547.44K |
NT$965.87 Million ≈ $30.43 Million |
-- |
About Icares Medicus Inc
ICARES Medicus, Inc., together with its subsidiaries, engages in the research, development, manufacturing, and sale of ophthalmic medical devices in Taiwan, the United States, England, Japan, Spain, China, and internationally. The company is also involved in the manufacturing, sales, and service of intraocular lenses (IOLs) and its implantation systems for use in treating cataracts, myopia, hyper… Read more